Literature DB >> 19849810

Gender differences in asthma prevalence: variations with socioeconomic disadvantage.

Catherine R Chittleborough1, Anne W Taylor, Eleonora Dal Grande, Tiffany K Gill, Janet F Grant, Robert J Adams, David H Wilson, Richard E Ruffin.   

Abstract

BACKGROUND AND
OBJECTIVE: Socioeconomic inequalities in health have been shown to vary for different diseases and by gender. This study aimed to examine gender differences in associations between asthma and socioeconomic disadvantage.
METHODS: Socioeconomic variables were assessed among men and women in the North West Adelaide Health Study, a representative population cohort (n = 4060) aged 18 years and over in metropolitan South Australia. Asthma was determined from spirometry and self-reported doctor diagnosis.
RESULTS: The prevalence of asthma was 12.0% (95% CI: 11.1-13.1), and was significantly higher among women (13.5%) than men (10.5%). For participants aged 18-64 years a higher prevalence of asthma was associated with an education level of secondary school or lower, or not being in the paid labour force among men, and with a gross annual household income of $20,000 or less among women. Among socioeconomically advantaged groups, the prevalence of asthma was significantly higher among women than men.
CONCLUSIONS: Socioeconomic disadvantage was associated with higher asthma prevalence, although this varied by gender depending on the indicator of socioeconomic position used. Men with low education or those not employed in the paid labour force had higher asthma prevalence than more socioeconomically advantaged men. Women with low income had higher asthma prevalence than those with higher income. Among all socioeconomically advantaged groups, and also the low-income group, women experienced a higher prevalence of asthma than men.

Entities:  

Mesh:

Year:  2009        PMID: 19849810     DOI: 10.1111/j.1440-1843.2009.01638.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  7 in total

1.  Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults.

Authors:  Deepa Rastogi; Molly Jung; Garrett Strizich; Pamela A Shaw; Sonia M Davis; Oana L Klein; Frank J Penedo; Andrew L Ries; Martha L Daviglus; Juan J Moreiras; Matthias A Salathe; Juan C Celedón; Carmen R Isasi; Robert C Kaplan
Journal:  Respir Med       Date:  2017-03-06       Impact factor: 3.415

2.  Associations between socioeconomic position and asthma: findings from a historical cohort.

Authors:  Sumaiya Patel; John Henderson; Mona Jeffreys; George Davey Smith; Bruna Galobardes
Journal:  Eur J Epidemiol       Date:  2012-06-14       Impact factor: 8.082

Review 3.  Operational definitions of asthma in recent epidemiological studies are inconsistent.

Authors:  Ana Sá-Sousa; Tiago Jacinto; Luís Filipe Azevedo; Mário Morais-Almeida; Carlos Robalo-Cordeiro; António Bugalho-Almeida; Jean Bousquet; João Almeida Fonseca
Journal:  Clin Transl Allergy       Date:  2014-08-04       Impact factor: 5.871

4.  Prevalence of Asthma and Respiratory Symptoms among University Students in Sari (North of Iran).

Authors:  Moslem Mohammadi; Behzad Parsi; Naghi Shahabi Majd
Journal:  Tanaffos       Date:  2016

5.  Understanding socio-economic inequalities in the prevalence of asthma in India: an evidence from national sample survey 2017-18.

Authors:  Rashmi Rashmi; Pradeep Kumar; Shobhit Srivastava; T Muhammad
Journal:  BMC Pulm Med       Date:  2021-11-15       Impact factor: 3.317

6.  Monosodium glutamate intake, dietary patterns and asthma in Chinese adults.

Authors:  Zumin Shi; Baojun Yuan; Gary A Wittert; Xiaoqun Pan; Yue Dai; Robert Adams; Anne W Taylor
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

7.  Influence of socioeconomic and demographic status on spirometry testing in patients initiating medication targeting obstructive lung disease: a population-based cohort study.

Authors:  Mette M Koefoed; Jens Søndergaard; René dePont Christensen; Dorte E Jarbøl
Journal:  BMC Public Health       Date:  2013-06-14       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.